NJ State Employees Deferred Compensation Plan’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-375
| Closed | -$5.5K | – | 485 |
|
|
2024
Q1 | $5.5K | Hold |
375
| – | – | ﹤0.01% | 480 |
|
|
2023
Q4 | $5.46K | Hold |
375
| – | – | ﹤0.01% | 483 |
|
|
2023
Q3 | $8.94K | Hold |
375
| – | – | ﹤0.01% | 482 |
|
|
2023
Q2 | $4.97K | Hold |
375
| – | – | ﹤0.01% | 487 |
|
|
2023
Q1 | $29.3K | Hold |
375
| – | – | ﹤0.01% | 488 |
|
|
2022
Q4 | $31.2K | Hold |
375
| – | – | 0.01% | 477 |
|
|
2022
Q3 | $35K | Hold |
375
| – | – | 0.01% | 471 |
|
|
2022
Q2 | $56K | Hold |
375
| – | – | 0.01% | 465 |
|
|
2022
Q1 | $91K | Hold |
375
| – | – | 0.01% | 485 |
|
|
2021
Q4 | $113K | Hold |
375
| – | – | 0.01% | 488 |
|
|
2021
Q3 | $155K | Hold |
375
| – | – | 0.02% | 481 |
|
|
2021
Q2 | $115K | Hold |
375
| – | – | 0.02% | 505 |
|
|
2021
Q1 | $77K | Hold |
375
| – | – | 0.01% | 508 |
|
|
2020
Q4 | $75K | Hold |
375
| – | – | 0.01% | 494 |
|
|
2020
Q3 | $62K | Hold |
375
| – | – | 0.01% | 475 |
|
|
2020
Q2 | $93K | Hold |
375
| – | – | 0.02% | 468 |
|
|
2020
Q1 | $68K | Hold |
375
| – | – | 0.02% | 453 |
|
|
2019
Q4 | $109K | Hold |
375
| – | – | 0.02% | 506 |
|
|
2019
Q3 | $102K | Buy |
+375
| New | +$102K | 0.02% | 510 |
|